Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

WELLCOVORIN

LEUCOVORIN CALCIUM

Standard Dose
EQ 25MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview WELLCOVORIN is listed in Drugs@FDA under application 089833 (ANDA).

Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength INJECTABLE;INJECTION - EQ 25MG BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview WELLCOVORIN is listed in Drugs@FDA under application 089833 (ANDA). Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength INJECTABLE;INJECTION - EQ 25MG BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.